Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Myriad Genetics Inc

NASDAQ: MYGN · Life Sciences · 8 alerts · CIK 899923

Share price
$5.57Close, Nov 16
Market cap
$534M
Shares outstanding
95.92MLatest SEC cover page
Sector
Life Sciences
Industry
In Vitro & In Vivo Diagnostic SubstancesSIC 2835

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Myriad Genetics Inc filings on SEC EDGAR ↗

4:51 PM ET 10-Q
Financial Results

Myriad Genetics Q3 2026 Results: Net Loss of $43.9M, Loss Widens

Myriad Genetics reported a revenue decline to $202.7 million for the third quarter of 2026, resulting in a net loss of $43.9 million. While the company significantly reduced its nine-month operating loss compared to the prior year—which was impacted by a $316.7 million impairment charge—it continues to face challenges with rising sales and marketing expenses.

Key figure
Net loss $43.9M
4:09 PM ET 8-K
Financial Results

Myriad Genetics Financial Results

Myriad Genetics reported Q3 2026 revenue of $202.7 million and raised its full-year revenue guidance mid-point. The company also highlighted a definitive agreement to sell its Prenatal Health business to Labcorp for $210 million in cash to focus on its Cancer Care Continuum and Mental Health segments.

Counterparty
Labcorp

“We have made meaningful progress on our path to accelerate profitable growth and strengthen the company’s financial profile. Our third quarter 2026 financial results exceeded our expectations, led by our on-going focus on the Cancer Care Continuum (CCC).”

Sam Raha, President and CEO, Myriad Genetics

“The sale of our Prenatal Health business is a decisive step to support our strategic intent to increase profitable growth by focusing on the Cancer Care Continuum including screening, treatment selection and monitoring along with remission surveillance.”

Sam Raha, President and CEO, Myriad Genetics

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.